期刊文献+

在体大鼠心肌缺血再灌注中MMP-2/9、TIMP-1/2mRNA和蛋白表达及MMP-2/9酶活性的同步动态变化 被引量:2

Synchronal dynamic alterations of the expressions of MMP2/9、TIMP-1/2mRNA and protein and activities of MMP-2/9 in rat myocardium in vivo during ischemia-reperfusion
下载PDF
导出
摘要 目的同步观察大鼠心肌缺血再灌过程中注基质金属蛋白酶(MMP-2)和MMP-9、基质金属蛋白酶抑制剂1(TIMP-1)和TIMP-2的mRNA和蛋白表达以及MMP-2和MMP-9的酶活性。方法80只大鼠随机分为8组:假手术组(Sham);单纯缺血30min组(I30min);再灌注1min组(R1min)、5min组(R5min)、10min组(R10min)、30min组(R30min)、再灌注1h组(R1h)和再灌注2h组(R2h),每组各10只。分别采用RT-PCR技术和免疫组化法检测心肌组织中MMP-2,-9和TIMP-1,-2的mRNA表达和蛋白表达;以酶谱分析法测血浆中MMP-2和MMP-9的酶活性。结果缺血再灌注过程中:(1)MMP-2、-9的mRNA表达呈升高趋势;MMP-2的mRNA表达在R1h组和R2h组分别与Sham组和I30min组比均显著差异;MMP-9的mRNA表达无明显变化;TIMP-1,-2的mRNA表达逐渐降低。MMP-2/TIMP-2,MMP-9/TIMP-1比值升高;(2)MMP-2,-9蛋白表达呈上升趋势,MMP-2蛋白表达于R2h达峰值;MMP-9蛋白表达R1h后开始显著升高;TIMP-1蛋白表达再灌注即刻即显著下降;TIMP-2蛋白表达于R5min开始显著下降;(3)MMP-2酶活性于R1min开始升高,R5min达峰值,R1h后逐渐降至假手术组水平;MMP-9酶活性呈升高趋势,R2h较Sham组呈显著差异。结论缺血再灌注过程中MMP-2,-9的mRNA与蛋白表达及酶活性较正常对照明显升高;TIMPs的mRNA和蛋白表达显著下调;MMPs/TIMPs比值失衡。MMPs/TIMPs比值失衡可能是治疗缺血再灌注损伤的一个潜在靶点。 Objective to observe synchronously alterations of the expression of MMP2/9、TIMP-1/2mRNA and protein and activities of MMP-2/9 in rat vivo myocardium during ischemia-reperfusion. Methods 80 rats were distributed randomly into 8 groups:sham ,simple ischemia for 30 minutes ,reperfusion for 1min,5min,10min,30min,1h and 2h. The expression of MMP-2,-9、TIMP-1,-2 mRNA and protein were determined by RT-PCR and immunohistochemistry,respectively. Activities of MMP-2,-9 in rats serum were detected by zymography. Results (1) The expression of MMP-2,-9 mRNA tended to increase during ischemia reperfusion. There was significant difference of MMP-2 mRNA expression in Rlh and R2 t, compared wltb Sham and 130rain, respectively, but there was no difference of MMP-9 mRNA expression in the whole I/R process. The expression of TIMP-1 ,-2 mRNA were presented to decrease. The ratio of MMP- 2/TIMP-2 and MMP-9/TIMP-1 were increased. (2) The expression of MMP-2, -9 protein had a trend of increase ; The expression of MMP-2 protein was peaked at 2h of reperfuslon. From 1h of reperfusion, there was a marked increase in expression of MMP-9 protein. From the beginning of repeffusion, the expression of TIMP-1 protein was presented significant decrease, and that of TIMP-2 protein was decreased obviously at the beginning of R5min. (3)The activity of MMP-2 began to increase at lmin of reperfusion, peaked at 5rain and gradually decreased to tbe level of group sham after 1tl of reperfusion. The activity of MMP-9 tended to increase. There was marked difference in R2h, compared with sham. Conclusions During myocardial ischemia-reperfusion, the mRNA and protein expressions and the activities of MMPs were increased signifi- cantly, the mRNA and protein expressions of TIMPs were downregulated dramatically, the balance of MMPs/ TIMPs was impaired. It was concluded that disbalance of MMPs/TIMPs may therefore be a potential target of treatment of myocardial reperfusion injury.
出处 《中国分子心脏病学杂志》 CAS 2009年第6期332-337,共6页 Molecular Cardiology of China
基金 福建省医学创新基金资助项目(No.2003-CX-18)
关键词 大鼠 缺血再灌注 基质金属蛋白酶 金属蛋白酶组织型抑制剂 Rat Ischemia-reperfusion Matrix metalloproteinase(MMP) Tissue inhibitor of metalloproteinase(TIMP)
  • 相关文献

参考文献24

  • 1Cheung PY, Sawicki G, Wozniak,et al. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation, 2000, 101(15) :1833-1839.
  • 2Lindsey M, Wedin K, Brown MD,et al. Matrix-dependent mechanism of neutrophil mediated release and activiation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation, 2001, 103(17) :2181-2187.
  • 3Schulze C J, Wang W, Suarez-Pinzon WL,et al. hnbalance between tissue inhibitor of metalloproteinase-4- and matrix metalloproteinases during acute myocardial [ correction of myoctardiall ischemia-reperfusion injury. Circulation, 2003, 107 (19) :2487-2492.
  • 4Danielsen CC, Wiggers H, Andersen HR. Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. J Mol Cell Cardiol, 1998, 30 : 1431-1442.
  • 5Romanic AM, Harrison SM, Bao W. Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. Cardiot,asc Res, 2002, 54 (3) :549-58.
  • 6Etoh T,Joffs C,Deschamps AI,et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am J Physiol Heart Circ Physiol, 2001, 281 (3) :H987-H994.
  • 7覃数,陈运贞,王志华.大白鼠实验性心肌缺血再灌注模型制备与心电图改变的特点[J].重庆医科大学学报,1998,23(1):8-11. 被引量:53
  • 8刘付平,姚宏伟,李俊.大鼠心肌缺血再灌注损伤模型的改进[J].安徽医科大学学报,2003,38(3):234-236. 被引量:53
  • 9陈淑萍,韩振京,刘峻岭.介绍一种可控家兔心肌缺血及再灌注动物模型[J].医学理论与实践,2004,17(2):125-126. 被引量:1
  • 10J.萨姆布鲁克,D.W.拉塞尔,著.黄培堂,等编译.分子克隆实验指南.北京:科学出版社,2002.8.

二级参考文献9

共引文献109

同被引文献29

  • 1张卓然,李鸿珠,高君,郭津,李宏霞,王丽娜,李弘,张伟华,赵雅君,张力,田野,徐长庆.丹参注射液抑制大鼠心肌缺血-再灌注损伤诱导的细胞凋亡[J].中医药学报,2009,37(4):14-17. 被引量:13
  • 2尤士杰,杨跃进,陈可冀,吴永健,荆志成,张健,胡奉环,白东峰,陈纪林,高润霖.通心络胶囊在急性心肌梗死血运重建后的有效性和安全性研究[J].疑难病杂志,2004,3(4):193-196. 被引量:47
  • 3陈义斌.川芎嗪对缺血再灌注所致大鼠离体心脏损伤的保护作用[J].医学信息(西安上半月),2006,19(5):826-829. 被引量:12
  • 4朱艳霞,张端莲.当归注射液对缺血再灌注损伤心肌细胞组织化学变化的影响[J].数理医药学杂志,2007,20(1):53-55. 被引量:4
  • 5Gibson JR,Cavernous transformation of the portal vein.J Pathol Bact. 1955;70:81-95.
  • 6De Gaetano AM,Lafortune M,Patriquin H,et al.Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. A JR Am J Roentgenol. 1995; 165:1151-1155.
  • 7Fernandez M, Mejias M, Angermayr B,et al. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.Hepatol,2005;43 (1):98-103.
  • 8Hijova E. Matrix metalloproteinases:their biological funcations and clinical implications,Bratisl Lek Listy,2005; 106(3): 127-132.
  • 9Chistiakov DA,Sobenin IA,Orekhov AN.Vascular extracelular matrix in atherosclerosis. Cardiol Rev,2013;21(6):270-288.
  • 10Fernandez M, Mejias M, Garcia-Pras E,et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and piatelet-derived growth factor blockade in rats. Hepatology. 2007;46(4):1208-1217.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部